Scivanta trades are quoted on the OTC Bulleting Board (www.otcbb.com) under the ticker symbol SCVM. Some web sites designate Scivanta as SCVM.OB.

Scivanta does not currently pay dividends.

Scivanta does not have a direct stock purchase plan.

Inquiries concerning the transfer of shares, change of address or lost certificates should be directed to:

Standard Registrar & Transfer Co., Inc.
12528 South 1840 East
Draper, Utah 84020
801 571 8844

The date for the 2008 Scivanta shareholder meeting is April 2, 2008. The meeting is scheduled to be held at 11:00 am at the offices of our corporate counsel, Giordano, Halleran & Ciesla, located at 125 Half Mile Road, Red Bank, New Jersey.

You may request information on-line through our website. or call Tom Gifford, our Executive Vice President and CFO, at 732-282-1620 x15.

To download an electronic copy of our latest Annual Report on form 10KSB, click here.

Scivanta's corporate address is 215 Morris Avenue, Spring Lake, NJ 07762.

Scivanta's product is under development, and is not sold at this time. After FDA approval, it will be offered in the US and abroad.

A complete listing of Scivanta officers is available here.

A complete listing of Scivanta’s Board is available here.

Scivanta’s fiscal year-end is October 31.